Ethanol increases phosphate-mediated mineralization and osteoblastic transformation of vascular smooth muscle cells

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 9, 2012, Pages 2219-2226

  Oros, Melinda ^a   Zavaczki, Erzsebet ^b   Vadasz, Csaba ^c,d   Jeney, Viktoria ^a   Tosaki, Arpad ^a   Lekli, Istvan ^a   Balla, Gyorgy ^a,b   Nagy, Laszlo ^a   Balla, Jozsef ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Ethanol; Smooth muscle cells; Vascular calcification

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; OSTEOCALCIN; PHOSPHATE; RUNX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CALCINOSIS; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OSTEOBLAST; PATHOLOGY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ALKALINE PHOSPHATASE; CALCINOSIS; CELL SURVIVAL; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ETHANOL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; OSTEOCALCIN; PHOSPHATES; TRANSCRIPTION FACTORS;

EID: 84865424902     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01533.x     Document Type: Article

References (44)

1. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000; 35: 1226-37.
2. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995; 92: 2157-62.
3. Sangiorgi G, Rumberger JA, Severson A, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998; 31: 126-33.
4. Beadenkopf WG, Daoud AS, Love BM. Calcification in the Coronary Arteries and Its Relationship to Arteriosclerosis and Myocardial Infarction. Am J Roentgenol Radium Ther Nucl Med. 1964; 92: 865-71.
5. Loecker TH, Schwartz RS, Cotta CW, et al. Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol. 1992; 19: 1167-72.
6. Lehto S, Niskanen L, Suhonen M, et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996; 16: 978-83.
7. Olson JC, Edmundowicz D, Becker DJ, et al. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes. 2000; 49: 1571-8.
8. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992; 86: 64-70.
9. Niskanen LK, Suhonen M, Siitonen O, et al. Aortic and lower limb artery calcification in type 2 (non-insulin-dependent) diabetic patients and non-diabetic control subjects. A five year follow-up study. Atherosclerosis. 1990; 84: 61-71.
10. Burke AP, Taylor A, Farb A, et al. Coronary calcification: insights from sudden coronary death victims. Z Kardiol. 2000; 89: 49-53.
11. Taylor AJ, Burke AP, O'Malley PG, et al. A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation. 2000; 101: 1243-8.
12. Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol. 2009; 171: 633-44.
13. McClelland RL, Bild DE, Burke GL, et al. Alcohol and coronary artery calcium prevalence, incidence, and progression: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2008; 88: 1593-601.
14. Lim SP, Batta K, Tan BB. Calciphylaxis in a patient with alcoholic liver disease in the absence of renal failure. Clin Exp Dermatol. 2003; 28: 34-6.
15. Goli AK, Goli SA, Shah LS, et al. Calciphylaxis: a rare association with alcoholic cirrhosis. Are deficiencies in protein C and S the cause? South Med J. 2005; 98: 736-9.
16. Ferreres JR, Marcoval J, Bordas X, et al. Calciphylaxis associated with alcoholic cirrhosis. J Eur Acad Dermatol Venereol. 2006; 20: 599-601.
17. Almafragi A, Vandorpe J, Dujardin K. Calciphylaxis in a cardiac patient without renal disease. Acta Cardiol. 2009; 64: 91-3.
18. Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001; 103: 987-92.
19. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001; 38: 938-42.
20. London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001; 38: 434-8.
21. Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis. 2001; 38: S34-7.
22. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol. 2003; 14: S300-4.
23. Shioi A, Nishizawa Y, Jono S, et al. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995; 15: 2003-9.
24. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87: E10-7.
25. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res. 2006; 98: 905-12.
26. Lau WL, Festing MH, Giachelli CM. Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1. Thromb Haemost. 2010; 104: 464-70.
27. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89: 765-71.
28. Giachelli CM, Steitz S, Jono S. Potential roles of bone matrix proteins in vascular calcification. Clin Calcium. 1999; 9: 20-7.
29. Zarjou A, Jeney V, Arosio P, et al. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol. 2009; 20: 1254-63.
30. Zarjou A, Jeney V, Arosio P, et al. Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res. 2010; 25: 164-72.
31. Block GA. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol. 2000; 54: 318-24.
32. Burke SK. Phosphate is a uremic toxin. J Ren Nutr. 2008; 18: 27-32.
33. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15: 2208-18.
34. Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001; 89: 1147-54.
35. Giachelli CM. Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol. 1999; 154: 671-5.
36. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89: 755-64.
37. Mukamal KJ, Chung H, Jenny NS, et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc. 2006; 54: 30-7.
38. Kabagambe EK, Baylin A, Ruiz-Narvaez E, et al. Alcohol intake, drinking patterns, and risk of nonfatal acute myocardial infarction in Costa Rica. Am J Clin Nutr. 2005; 82: 1336-45.
39. Yuan JM, Ross RK, Gao YT, et al. Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ. 1997; 314: 18-23.
40. Clarke M, Bennett M. The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability. Am J Nephrol. 2006; 26: 531-5.
41. Proudfoot D, Skepper JN, Hegyi L, et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000; 87: 1055-62.
42. Proudfoot D, Davies JD, Skepper JN, et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation. 2002; 106: 3044-50.
43. Li W, Li J, Liu W, et al. Alcohol-induced apoptosis of canine cerebral vascular smooth muscle cells: role of extracellular and intracellular calcium ions. Neurosci Lett. 2004; 354: 221-4.
44. Speer MY, Li X, Hiremath PG, et al. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem. 2010; 110: 935-47.